• Dr shraddha sharma

Depression is extremely common as a disorder. It is estimated that 20 to 25% of women and 12 to 15% of men will suffer from a major depression during their life. Depression is normal feature of our hard life. Depression is the most common disease of psychiatry as cough and cold is in dept. of medicine. MedhyaRasayanaYog is one of such drug which is said to be Medhahitam, Rasayana, Vrsya and acts as mood elevators and promotes the sense of well being. The present clinical trial was conducted to evaluate the efficacy of Medhyarasayana and Shirodhara in 45 patients having symptoms of Depression. The effect of therapy was assessed adopting “Hamilton’s depression rating scale”. MedhyaRasayana and Shirodhara showed significant (P<.001) improvement in all parameters of Hamilton’s Depression Rating scale. It was inferred that most of the contents of the formulation of MedhyaRasayana are Medhya, Balya, Dhatupushtikara, Brimhaniya, Jivaniya, and Agnivardhaka. The drugs may act as adoptogens, antioxidants, immunostimulents, antistress, nootrophics, antidepressants, or may have other geriatrics benefits. Hence it was concluded that MedhyaRasayanaYog can be used as an alternative treatment to manage depression.

Keywords: MedhyaRasayana, shirodhara, Stress.

"Clinico comparative trial of charkokta medhyarasayan and shirodhara in patients of mansik avsad ( mental depression)", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.6, Issue 1, page no.132-140, January-2019, Available :http://www.jetir.org/papers/JETIR1901615.pdf

"Clinico comparative trial of charkokta medhyarasayan and shirodhara in patients of mansik avsad ( mental depression)", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.6, Issue 1, page no. pp132-140, January-2019, Available at : http://www.jetir.org/papers/JETIR1901615.pdf